サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1780820

蛍光誘導手術システムの世界市場

Fluorescence Guided Surgery Systems

出版日
ページ情報
英文 370 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
蛍光誘導手術システムの世界市場
出版日: 2025年07月31日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 370 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

蛍光誘導手術システムの世界市場は2030年までに4億5,490万米ドルに達する見込み

2024年に2億860万米ドルと推定される蛍光誘導手術システムの世界市場は、2030年には4億5,490万米ドルに達し、分析期間2024-2030年のCAGRは13.9％で成長すると予測されます。本レポートで分析したセグメントの1つであるSPYシステムは、CAGR13.0％を記録し、分析期間終了時には2億970万米ドルに達すると予測されます。PDEシステムズ分野の成長率は、分析期間でCAGR 13.3％と推定されます。

米国市場は5,680万米ドルと推定、中国はCAGR18.4％で成長予測

米国の蛍光誘導手術システム市場は、2024年には5,680万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9,630万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは18.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.3％と12.3％と予測されています。欧州では、ドイツがCAGR 11.0%で成長すると予測されています。

世界の蛍光誘導手術システム市場- 主要動向と促進要因まとめ

なぜ蛍光誘導手術が腫瘍学と脳神経外科のゲームチェンジャーになりつつあるのか？

蛍光誘導手術（Fluorescence Guided Surgery、FGS）は、蛍光色素を用いて腫瘍やリンパ節、重要な組織をリアルタイムで可視化することで、手術の精度に革命をもたらしています。この技術は腫瘍学、神経外科、低侵襲手術において特に価値があり、完全切除には正確な腫瘍マージンの検出が不可欠です。個別化されたがん治療の採用の増加と固形がんの有病率の増加が、FGSシステムの需要を牽引しています。さらに、近赤外（NIR）イメージングと標的蛍光造影剤の進歩は、手術精度を高め、再発率を低下させ、患者の生存率を向上させています。精密医療が普及するにつれ、蛍光ガイド下手術は複雑な外科手術の標準となりつつあります。

どのような技術の進歩が蛍光誘導手術システムを向上させているのか？

分子イメージング、AIを駆使した蛍光マッピング、生体適合性造影剤におけるブレークスルーが、FGSシステムの有効性を高めています。がん組織に選択的に結合する標的蛍光プローブの開発により、腫瘍の可視性が向上し、健康な構造へのダメージが減少しています。AIを駆使したイメージング・ソフトウェアは、リアルタイムの組織鑑別を可能にし、手技中の外科医をより効果的に誘導しています。さらに、蛍光とMRIやPETスキャンなどの他の画像モダリティを組み合わせたハイブリッド画像システムは、より良い外科的意思決定のための多層的な洞察を提供しています。ロボット支援蛍光ガイド下手術の統合は、複雑な手術の精度をさらに高め、侵襲を減らしています。

規制と市場動向は蛍光誘導手術にどのような影響を与えているか？

FDAやEMAなどの規制機関は、蛍光造影剤や画像システムの承認を監督し、その安全性と有効性を保証しています。術中イメージングと精密腫瘍学への重点の高まりが、がん治療プロトコールにおけるFGSの採用を促進しています。さらに、低侵襲手術への需要が、病院が先進的な蛍光ガイド下腹腔鏡手術システムやロボット手術システムに投資することを後押ししています。AI支援手術計画ツールの拡大も市場成長に影響を与えており、腫瘍や血管構造のより良い術前マッピングを可能にしています。手術技術の進化に伴い、蛍光ガイド下手術は患者の転帰を改善するために不可欠なツールになりつつあります。

蛍光誘導手術システム市場の今後の成長の原動力は？

FGSの将来は、AIを活用した画像解析、次世代蛍光造影剤、ロボット支援手術プラットフォームの採用拡大によって形作られつつあります。特定のがんをターゲットとした分子イメージング色素の開発により、腫瘍の位置特定と手術精度がさらに向上します。AIを活用した意思決定支援ツールは、リアルタイムの術中ガイダンスを強化し、手術ミスを減らし、切除の完全性を向上させる。さらに、遠隔手術や遠隔ロボット手術の応用が拡大すれば、十分なサービスを受けていない地域でもFGSがより利用しやすくなります。精密手術の需要が高まるにつれ、蛍光誘導手術は現代の外科腫瘍学と神経外科を再定義し続けると思われます。

セグメント

タイプ（SPYシステム、PDEシステム、VS3イリジウムシステム、その他）、手術（観血的手術、腹腔鏡／内視鏡手術）、アプリケーション（がん手術、心臓血管外科、その他）

調査対象企業の例

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging S.p.A.
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems（Danaher Corporation）
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc.（Stryker）
  • Olympus Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31004

Global Fluorescence Guided Surgery Systems Market to Reach US$454.9 Million by 2030

The global market for Fluorescence Guided Surgery Systems estimated at US$208.6 Million in the year 2024, is expected to reach US$454.9 Million by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. SPY Systems, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$209.7 Million by the end of the analysis period. Growth in the PDE Systems segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.8 Million While China is Forecast to Grow at 18.4% CAGR

The Fluorescence Guided Surgery Systems market in the U.S. is estimated at US$56.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$96.3 Million by the year 2030 trailing a CAGR of 18.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Fluorescence Guided Surgery Systems Market - Key Trends & Drivers Summarized

Why Is Fluorescence Guided Surgery Becoming a Game-Changer in Oncology and Neurosurgery?

Fluorescence guided surgery (FGS) is revolutionizing surgical precision by enabling real-time visualization of tumors, lymph nodes, and critical tissues using fluorescent dyes. This technique is particularly valuable in oncology, neurosurgery, and minimally invasive procedures, where precise tumor margin detection is essential for complete resection. The growing adoption of personalized cancer treatment and the increasing prevalence of solid tumors are driving demand for FGS systems. Additionally, advancements in near-infrared (NIR) imaging and targeted fluorescence contrast agents are enhancing surgical accuracy, reducing recurrence rates, and improving patient survival. As precision medicine gains traction, fluorescence guided surgery is becoming a standard in complex surgical interventions.

What Technological Advancements Are Improving Fluorescence Guided Surgery Systems?

Breakthroughs in molecular imaging, AI-powered fluorescence mapping, and biocompatible contrast agents are enhancing the efficacy of FGS systems. The development of targeted fluorescent probes that bind selectively to cancerous tissues is improving tumor visibility and reducing damage to healthy structures. AI-driven imaging software is enabling real-time tissue differentiation, guiding surgeons more effectively during procedures. Additionally, hybrid imaging systems combining fluorescence with other imaging modalities, such as MRI and PET scans, are providing multi-layered insights for better surgical decision-making. The integration of robotic-assisted fluorescence guided surgery is further enhancing precision and reducing invasiveness in complex operations.

How Are Regulations and Market Trends Influencing Fluorescence Guided Surgery?

Regulatory agencies such as the FDA and EMA oversee the approval of fluorescence contrast agents and imaging systems, ensuring their safety and effectiveness. The increasing emphasis on intraoperative imaging and precision oncology is driving the adoption of FGS in cancer treatment protocols. Additionally, the demand for minimally invasive procedures is encouraging hospitals to invest in advanced fluorescence-guided laparoscopic and robotic surgery systems. The expansion of AI-assisted surgical planning tools is also influencing market growth, enabling better preoperative mapping of tumors and vascular structures. As surgical technology evolves, fluorescence guided surgery is becoming an indispensable tool for improving patient outcomes.

What’s Driving the Future Growth of the Fluorescence Guided Surgery Systems Market?

The future of FGS is being shaped by AI-enhanced imaging analytics, next-generation fluorescent contrast agents, and the increasing adoption of robotic-assisted surgical platforms. The development of targeted molecular imaging dyes for specific cancers will further improve tumor localization and surgical precision. AI-powered decision support tools will enhance real-time intraoperative guidance, reducing surgical errors and improving resection completeness. Additionally, the expansion of tele-surgical and remote robotic surgery applications will make FGS more accessible in underserved regions. As demand for precision surgery grows, fluorescence guided surgery will continue to redefine modern surgical oncology and neurosurgery.

SCOPE OF STUDY:

The report analyzes the Fluorescence Guided Surgery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (SPY Systems, PDE Systems, VS3 Iridium Systems, Other Types); Surgery (Open Surgery, Laparoscopy / Endoscopy Surgery); Application (Cancer Surgery Application, Cardiovascular Surgery Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging S.p.A.
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems (Danaher Corporation)
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc. (Stryker)
  • Olympus Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fluorescence Guided Surgery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Preference for Precision-Guided Oncologic Surgeries Propels Market Growth
    • Advancements in Near-Infrared and Multispectral Imaging Improve Visualization Accuracy
    • Increasing FDA and CE Approvals for Targeted Imaging Agents Expand Clinical Use
    • Growing Application in Neurosurgery, Urology, and Reconstructive Surgery Broadens Scope
    • Integration With Robotic Surgery Platforms Enhances Surgical Workflow Synergies
    • Development of Target-Specific Fluorescent Dyes Improves Tumor Margin Identification
    • Growth in Minimally Invasive Surgery Drives Demand for Real-Time Visualization Tools
    • AI-Based Image Enhancement Technologies Enable Faster, More Accurate Interpretation
    • Hospital Investments in Hybrid Operating Rooms Support System Installations
    • Surgeon Training and Awareness Campaigns Boost Institutional Adoption Rates
    • Demand for Organ-Sparing Surgical Techniques Encourages Use in High-Precision Interventions
    • Strategic Collaborations Between Imaging System Manufacturers and Pharma Firms Accelerate Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fluorescence Guided Surgery Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for SPY Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for PDE Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for VS3 Iridium Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Laparoscopy / Endoscopy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cancer Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION